INTRODUCTION
China, eradication is proving hard to enforce, and it is even difficult to sustain the gains achieved in practical work limited by their scales of breeding, the level of management, environmental control, and so on. It is inefficient to prevent and control M. gallisepticum by medication because a medication may not eliminate M. gallisepticum from a flock and the birds are capable of transmitting the M. gallisepticum horizontally as well as vertically (Hein, 2004) . There are also other problems such as high cost and drug residues. Therefore, vaccination has become the main approach in controlling M. gallisepticum.
Currently, 2 types of vaccines, live and inactivated vaccines, are available for the control of M. gallisepticum. Inactivated vaccines could play a certain role in the control, but there are disadvantages such as high labor cost, local reactions at the injection site, lack of effectiveness in eliminating M. gallisepticum, and other disadvantages. Kleven (1997) indicated that live M. gallisepticum vaccines could be effective in controlling economic losses and may be used as tools in eradication programs. Cell-mediated immunity is thought to play a role in the systemic and local antibody responses to M. gallisepticum (Gaunson et al., 2000; Noormohammadi et al., 2002) . Live M. gallisepticum vaccine is a better option to protect against M. gallisepticum infection than inactivated vaccines (Hein, 2004) . Available live M. gallisepticum vaccines applied widely are produced from the F strain M. gallisepticum (FMG) , and more recently, ts-11 strain M. gallisepticum (ts-11) and 6/85 strain M. gallisepticum (6/85; OIE, 2008) . Producers in the United States experienced a re-emergence of more pathogenic strains of M. gallisepticum in flocks vaccinated with either the ts-11 or 6/85 vaccine that resulted in unnecessary economic loss (Poultry Technical Services Team, 2005) . Compared with either ts-11 or 6/85 vaccine, chickens vaccinated with the FMG vaccine in the field show significant protection against virulent M. gallisepticum. Early inoculation or vaccination with FMG may help reduce losses in the performance of birds as a result of infection by field strains of M. gallisepticum (Luginbuhl et al., 1976; Yoder et al., 1984) . Furthermore, consistent use of FMG vaccine could displace more virulent endemic M. gallisepticum populations (Kleven et al., 1990; Brown et al., 1995; Peebles and Branton, 2012) , so as to achieve the purpose of eliminating M. gallisepticum in the future.
The objective of the present study was to understand and explore influences of FMG vaccination before laying on productive and reproductive performance of commercial parent broiler chicken breeders on a multiage farm, through evaluating BW, laying performance, egg quality parameters, fertility and hatchability of hatching eggs, and so on, throughout a complete egg laying cycle in Lingnan Yellow broiler chicken breeders inoculated with the FMG vaccine at 1 d and again at 12 wk of age, and characterizing possible physiological changes, including air-sac lesions and reproductive organ characteristics.
MATERIALS AND METHODS

Pullet Housing and Management
Three thousand 1-d-old pullets of a single genetic strain, Lingnan Yellow Chicken, were obtained from a commercial source that was randomly divided into 2 treatment groups that were either vaccinated with FMG (FMG-vaccinated group) or not vaccinated with FMG (FMG-free group). The breeder flocks, which were certified as free of M. gallisepticum, were reared on the same multi-age farm with a long history of mycoplasmosis. Pullets in the brooding period, up until the time that they were 7 wk of age, were maintained on clean dry litter in a conventional house. Flock density at placement was 30 birds/m 2 . At 8 d and again at 4 wk of age, chickens were also vaccinated for Newcastle disease and infectious bronchitis via drinking water. Pullets were vaccinated at 2 wk and again at 5 wk of age for infectious bursal disease by the same route.
At 7 wk of age, hens that had a sex identification problem or did not meet the criteria for color pattern, size, and appearance were eliminated. Subsequently, all the remaining pullets were transferred to the cage facilities that had been thoroughly disinfected. Flock density at placement was 20 birds/m 2 . The hens from the FMG-vaccinated group and FMG-free group were reared in 2 different henhouses. A certain proportion of breeder cocks were reared in each henhouse, and the cocks of the FMG-vaccinated group were treated as hens.
At 12 wk of age, each treatment group was randomly divided into 4 replicate units. Lighting was maintained at 13 h per day before laying. Beginning at the onset of lay, the artificial lighting schedule was increased 0.5 h/wk until a 16L:8D cycle was achieved. Broiler breeders were maintained on that schedule through the remainder of the experiments. For the entirety of the trial, broiler breeders had ad libitum access to water. Their diets were provided over the course of the trial as follows: 0 to 7 wk, starter; 7 wk to onset of lay, grower; and onset of lay to conclusion of experiment, layer. These diets were formulated with the appropriate ingredients. Commercial animal feeding operations were maintained as much as possible.
FMG Inoculation
Pullets in the vaccinated group treated with FMG were inoculated via eye drop in the right eye at 1 d and 12 wk of age with 0.03 mL of FMG vaccine marketed by Nanjing Tianbang Bio-Industry Co. Ltd., Nanjing, China. Similarly, pullets designated as controls were sham-inoculated via eye drop in the right eye with 0.03 mL of PBS. Pullets in which antibiotics are being used (especially those with anti-mycoplasma activity) must be avoided within 2 to 4 d after vaccination and at least 20 d after vaccination.
Mycoplasma Detection
Cotton swab samples were collected from tracheas of 20 randomly selected broiler breeder hens of each treatment group at each of 7 ages (5 d, and 12, 20, 26, 32, 43, and 50 wk) . Each of these samples was tested for the presence of FMG and virulent strain of M. gallisepticum (VMG) by the duplex PCR method described by Ding et al. (2011) . The virulent strain R of M. gallisepticum as a positive control for PCR test for detection of VMG was provided by Nanjing Tianbang BioIndustry Co. Ltd.
Productive Performance
Individual BW of 20 randomly selected broiler breeder hens in each group were recorded at 12, 16, 20, 23, 26, 29, 32, 35, 38, 41, 43, 47 , and 50 wk of age. Commensurate with the production of the first egg (22 wk of age), eggs from both groups were collected daily until trial termination at 50 wk. Egg production data for FMGvaccinated and FMG-free broiler breeder hens were expressed as percentage hen-day production. Eight eggs per unit were collected to determine egg weight (EW) at 26, 32, 35, 38, and 43 wk of age. During those same weeks listed above for EW, 4 units in each group were used in a study for the determination of feed conversion (g of feed intake/g of eggs produced). Total feed consumed and numbers of eggs produced per unit were recorded each week to derive feed conversion. After eggs were weighed, eggs were collected at 26 (prepeak), 32 (peak), 43 wk of age (postpeak) to determine egg quality parameters. Eggshell strength (ESS) was measured using an eggshell strength meter (FHK NFN388, Fujihira Industry Co. Ltd., Tokyo, Japan), egg-specific gravity (ESG) was measured by the method described by Kermanshahi and Classen (2001) , egg shape index (ESI) was measured by a egg form coefficient measuring instrument (FHK NFN385, Fujihira Industry Co. Ltd.). Then, blood-meat (B-M) spots and Haugh unit (HU) score were determined by breaking each egg. The B-M spots were determined by using the methods described by Branton et al. (2000) . The HU were scored using an egg quality gauge (FHK NFN381, Fujihira Industry Co. Ltd.) and by a technique described by Austic and Nesheim (1990) . After the measurement of B-M spots and HU score, eggs were separated, and the yolk, albumen, and eggshell weights were determined and expressed as percentages of EW. Yolk:albumen ratio was expressed as a fraction of the percentages of yolk weight (numerator) and albumen weight (denominator). Eggshell thickness was determined using the same shells used to determine eggshell percentage. Eggshell thickness was measured in 3 points at the egg equator using an eggshell thickness gauge (FHK NFN380, Fujihira Industry Co. Ltd.), and calculating the average among the 3 points (De Reu et al., 2006).
Reproductive Performance
Six hundred hatching eggs of each treatment group were randomly selected at each of 3 ages (26, 32, and 43 wk). Experimental eggs were collected 2 times daily and stored for 2 d at 14 to 16°C and 65% RH before setting. A total of 1,200 eggs collected at 1 of 3 ages were distributed randomly among 8 incubator trays (150 eggs per tray), with treatment groups uniformly represented in each 3 trays. The 8 trays were randomly placed into a single EI incubator (EIF/CXDZ15120, Qingdao Xingyi Electronic Equipment Co. Ltd., Qingdao, China) to 18 d of incubation. The incubator air temperature set point was 37.6°C. Relative humidity was automatically controlled at 55%, and eggs were turned through a 90° angle 12 times daily through 18 d of incubation. Both experimental groups were placed in a single hatcher (EICDXDZ15120, Qingdao Xingyi Electronic Equipment Co. Ltd.) at the time of transfer (18 d of incubation) in all experiments. The hatcher air temperature set point was 37.3°C, and RH was automatically controlled at 60%.
At the time of removing the chicks from the hatchers (21.5 d of incubation), the number of chicks hatched from each group was counted and all unhatched eggs were opened and examined macroscopically by an experienced individual to determine percentage fertility. Percentage fertility was calculated as the number of fertile eggs per 100 hatching eggs set. Percentage hatchability was calculated as the number of chicks hatched per 100 hatching eggs set. Percentage second-quality chicks was calculated as the number that were not able to stand properly or chicks that showed visible signs of poor incubation conditions, such as improperly healed navels, per 100 chicks hatched.
Pathologic Examination
At 20, 32, and 50 wk of age, air sacs from 1 randomly selected hen in each of 4 units in both FMG-vaccinated and FMG-clean groups were examined and lesions were scored by the method described by Rodriguez and Kleven (1980) . At 32 and 50 wk of age, the entire ovary was removed from 1 randomly selected hen in each of 4 units in both groups, and the number of mature (diameter ≥12 mm) yellow ovarian follicles was recorded for each hen as described by Burnham et al. (2002a) . Then their oviducts were removed and the lengths of the oviduct, infundibulum, magnum, isthmus, uterus, and vagina were also examined.
At 32 and 50 wk of age, one tissue sample from the ovary, infundibulum, magnum, isthmus, uterus, and vagina was harvested from 1 hen in each of 4 units in both groups. Tissue samples were prepared into paraffin section as described by Peebles et al. (2006) . Each tissue sample was observed and scored for the presence or absence of lymphoid and heterophil infiltrates as described by Branton et al. (2000) . Treatment assignments were unknown to the evaluator during the scoring procedure.
Statistical Analyses
A completely randomized experimental design was used. All data were analyzed using the MIXED procedure of SAS software (SAS Institute, 2003) , except percentages were compared between treatments using ttest. Global effects and differences among least squares means were considered significant at P < 0.05.
RESULTS
Survival of FMG and Field M. gallisepticum
In FMG-vaccinated parent broiler chicken breeder flocks, all initial PCR test results obtained from 5-dold pullets were negative for FMG (Table 1) . Then, at ages 12, 20, 26, 32, 43, 50 wk, percentages of FMGpositive birds were 65 to 95%, and maintained an especially high level (≥85%) after 20 wk of age. In the FMG-free group, however, all PCR test results were negative for FMG during the same period. Percentages of VMG-positive hens in FMG-vaccinated group were from 60 to 90%. Interestingly, a decreasing tendency was shown, gradually starting from 12 wk of age. However, percentages of VMG-positive birds in FMG-free group maintained a high level (≥90%) over the experimental period.
Productive Performance
The FMG vaccine main effects were not significant for BW (Table 2) . Weekly EP for both groups are provided in Figure 1 . Initiation of lay was delayed 3 d for broiler breeder hens from the FMG-vaccinated group in comparison with those from the FMG-free group. An increase in EP of hens in the FMG-vaccinated group began at wk 32 so that EP became significantly more than that of breeding hens in the FMG-free group. This same comparative pattern of EP continued each week from 34 to 41 wk of age. The FMG vaccine main effect (P < 0.05) was observed for feed conversion. Feed conversion of hens in the FMG-vaccinated group was significantly less at 32, 35, 38, and 43 wk compared with those in the FMG-free group (Table 3) . Instead, there were no significant differences between the different treatment groups for EW at 26, 32, 35, 38, and 43 wk of age.
Egg quality parameters for both groups at 26, 32, and 43 wk of age are provided in Table 4 . Eggs from hens in FMG-vaccinated group at 26 wk of age had a significantly higher HU score and at 32 wk of age had a significantly higher eggshell thickness and lower incidence of B-M spots compared with the other treatment group. There were no significant differences between the different treatment groups for other egg quality parameters at 26, 32, or 43 wk of age.
Reproductive Performance
Fertility, hatchability, and second-quality chicks for both groups at 26, 32, and 43 wk of age are provided in Table 5 . There were no significant differences between the different treatment groups for fertility and secondquality chicks at 26 and 32 wk of age, but eggs from hens in the FMG-vaccinated group had significantly higher hatchability compared with the other treatment group. At 43 wk of age, however, there were no significant differences between the different treatment groups for fertility, hatchability, and second-quality chicks.
Pathologic Examination
Air-sac lesions for FMG-vaccinated and FMG-free groups at 20, 32, and 50 wk of age are provided in Table 6 . The air-sac lesions observed in FMG-vaccinated group was less than that observed in the FMGfree group. The number of maximum follicles for both groups at 32 and 50 wk of age is provided in Table 7 . There were no significant differences between the different treatment groups for the number of maximum follicles. Infundibulum, magnum, isthmus, uterus, vagina, and oviduct lengths for both groups at 32 and 50 wk of age are provided in Table 8 . At 32 wk of age, uteruses of hens in the FMG-vaccinated group were significantly longer compared with the other treatment group. No significant differences (P < 0.05) were demonstrated between the treatment groups for histopathologic lesion scores within any of the tissues sampled (data not shown).
DISCUSSION
The economic impact of chronic respiratory infections associated with M. gallisepticum on a multi-age farm is enormous. Mycoplasma gallisepticum can cause respiratory tract infection and airsacculitis, and once a bird is infected with M. gallisepticum it is generally considered chronically infected for life (Austic and Nesheim, 1990; Burnham et al., 2002b) . Mycoplasma gallisepticum transmission from mature hens to replacement pullets has led to great difficulties in controlling M. gallisepticum. Unfortunately, the implementation of strict biosecurity measures is difficult on multi-age farms, and the most efficient solution may be to establish an M. gallisepticum vaccination program (Bermudez and Kalbac, 1988) . The FMG is known to be relatively low in virulence, poorly transmissible, and able to displace the original field strain (Kleven et al., 1990) . In the present study, it was found that percentages of VMG-positive birds remained stable, but percentages of VMG-positive birds showed a decreasing tendency gradually over time after FMG vaccine inoculation through detecting the presence of M. gallisepticum. The results show that the FMG vaccine maybe have the ability to displace the virulent field strains of M. gallisepticum. The mean lesion score of air-sac lesion of birds in FMG-vaccinated group was 0.75 at 26, 32, and 50 wk of age, significantly less than the FMG-free group. This indicates that FMG vaccine may be capable of offering effective protection for air-sacs of parent broiler chicken breeders. Abd-elMotelib and Kleven (1993) compared the immune efficacy of 3 live M. gallisepticum vaccine strains (ts-11, 6/85, and FMG) and one of bacterins and observed airsac lesions of vaccinated chickens 10 d postchallenge. The FMG-vaccinated hens had a mean lesion score of air-sac lesions of 0.18, had the best protection against airsacculitis, less protection was observed in the ts-11 and 6/85 groups, and mean lesion scores were 1.25 and 1.32, respectively; no protection against airsacculitis was observed in bacterin-vaccinated hens. The FMG vaccine may offer protection for the health of parent broiler chicken breeders against colonization by field strains of M. gallisepticum. 63.61 ± 7.22 61.91 ± 4.14 3.47 ± 0.12 b 3.80 ± 0.08 a a,b Within week of age, means among treatment groups with no common superscript differ significantly (P < 0.05).
1 n = 32.
Along with affecting the respiratory apparatus, M. gallisepticum infection in hens also causes reduced EP and financial losses (Mohammed et al., 1987; Hein, 2004; OIE, 2008) . Truscott et al. (1974) and reported that they were protected against decreases in EP of hens vaccinated with lowvirulence live M. gallisepticum. Carpenter et al. (1981) reported that FMG-vaccinated flocks will produce 7.0 more eggs per hen per year, when the performance of FMG-vaccinated and M. gallisepticum-infected flocks is compared. In the present study, an increase in EP of broiler breeder hens in the FMG-vaccinated group during peak of lay was compared with the FMG-free group, and especially EP became significantly more than that of hens in the FMG-free group at 32, 34, 35, 36, 37, 38, 39, 40 , and 41 wk of age. The results demonstrate that FMG vaccine inoculation improves EP of hens in FMG-vaccinated group during peak of lay and effectively restrain adverse impacts of M. gallisepticum infection. Burnham et al. (2002b) found that all birds inoculated with FMG laid their first egg approximately 1 wk after FMG-free controls. In this study, however, it was found that initiation of lay of hens in FMGvaccinated group was delayed 3 d compared with the FMG-free group. This may be because not all hens in the FMG-free group were infected by M. gallisepticum before laying. Each reproductive tract segment plays a corresponding and important role within a certain time frame on the formation of an egg (Austic and Nesheim, 1990; Johnson, 2000) . Mycoplasma gallisepticum may colonize various regions of the female reproductive tract and disrupt egg formation, and consequently result in reduced rates in EP (Burnham et al., 2002a) . Mohammed et al. (1987) and Yoder (1991) reported that feed efficiency was reduced in flocks naturally infected with M. gallisepticum. In this study, feed conversion of hens inoculated FMG vaccine on multi-age farms was improved; however, EW was not significantly improved.
Mycoplasma gallisepticum may have a unique ability to colonize and impair certain reproductive processes in commercial birds and lead to a delay in the development of the ovary and oviduct during prepeak EP (Carlson and Howell, 1967; Domermuth et al., 1967; Burnham et al., 2002a) . In the study, the result that uteruses of hens in FMG-vaccinated group were significantly longer compared with the other treatment group at 32 wk of age indicates that the FMG vaccine inoculation has a protective function against the effect of M. gallisepticum infection on development of oviduct. The uterus is the location of formation of eggshells, and eggshell formation may be influenced by shortening of the uterus in the FMG-vaccinated group. At peak EP (32 wk of age), eggs from hens in the FMG-vaccinated group had a significantly higher eggshell thickness compared with the FMG-free group. The characteristics of eggshell are thinness and porousness, and it has been proposed that the mechanical properties of the shell that ensure the integrity of the diffusion pathways throughout incubation are of equal importance to those that protect the embryo from mechanical damage (Tullett, 1984; Paganelli et al., 1987) . The pore rate of eggshell increased and the water vapor conductance improved when shell thickness increased in the FMGvaccinated group, and consequently the hatchability of hatching egg was affected. Besides, hatchability of the hatching egg was affected by HU or incidence of B-M spots. The results for determination of egg quality show that eggs from hens in the FMG-vaccinated group at 26 wk of age had a significantly higher HU score and at 32 wk of age had lower incidence of B-M spots compared with the FMG-free group. Interestingly, eggs from hens in the FMG-vaccinated group had a significantly higher hatchability compared with the FMG-free group at 26 and 32 wk of age. Quality of the egg may affect hatchability (Heier and Jarp, 2001; Wolc et al., 2010) . Previous work also has shown that M. gallisepticum is transmitted to chicks through the egg in hens infected by M. gallisepticum Barbour et al., 2000) . The FMG vaccine produces persistent protection for reproductive systems of hens and dramatically reduces the vertical transmission of M. gallisepticum (Poultry Technical Services Team, 2005; Olanrewaju et al., 2009) , consequently hatchability of hatching egg is increased significantly. The maintenance of M. gallisepticum-free breeder flocks through eradication remains the best method of M. gallisepticum control; however, even though most commercial poultry flocks in developed countries such as the United States are raised free of M. gallisepticum via strategic biosecurity and monitoring programs, they are still at risk of infection (Burnham et al., 2002b; Hein, 2004) . Consequently, M. gallisepticum vaccines could still play an important role in controlling M. gallisepticum currently. The results in the study show improved and enhanced EP, feed conversion, egg quality, and hatchability of hatching eggs from broiler breeder hens inoculated with the FMG vaccine, and indicate that it may effectively reduce the risk associated with field M. gallisepticum and facilitate the productive and reproductive performance of commercial parent broiler chicken breeders by FMG vaccine inoculation before laying on a multi-age farm.
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